Section of Benign Hematology
The mission of the Section of Benign Hematology is to provide outstanding care to patients with cancer who have diseases of the blood. In support of this mission, our goals are:
- To provide clinical support for patients with cancer who have non-malignant disorders of bleeding, thrombosis, platelets, red cells and white cells. We work collaboratively with primary providers to optimize clinical outcomes, including long-term outcomes;
- To identify and explore areas of research—both basic and clinical—that provide avenues to improved standards-of-care for patients with cancer who are suffering from blood diseases; and
- To educate patients, students, post-doctoral trainees, mid-level providers and physician colleagues about the impact and natural history of hematological disorders that emerge or complicate the course of a patient’s cancer and its treatment.